Showing results (191-200 of 531) with videos related to

Sort By:
Pageof 54
The Annals of Thoracic Surgery|August 28, 2007
Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four/heparin antibodiesCornelius M Dyke, Gabriel Aldea, Andreas Koster, et al.
The American Journal of Cardiology|June 15, 2007
Association of prerandomization anticoagulant switching with bleeding in the setting of percutaneous coronary intervention (A REPLACE-2 analysis)C Michael Gibson, Yuli Ten, Sabina A Murphy, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 31, 2005
Bivalirudin vs heparin in percutaneous coronary intervention: a pooled analysisRamin Ebrahimi, A Michael Lincoff, John A Bittl, et al.
European Heart Journal|June 19, 2007
Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approachEugenia Nikolsky, Roxana Mehran, George Dangas, et al.
The American Journal of Cardiology|August 15, 2022
Longitudinal High-Sensitivity C-Reactive Protein and Longer-Term Cardiovascular Outcomes in Optimally-Treated Patients With High-Risk Vascular DiseaseIryna Dykun, Donald Clark, Julie Carlo, et al.
JACC. Case Reports|July 4, 2025
Coronary Stent Infection in Acute Double Valve EndocarditisFilip Stembal, Maria Bakaeen, Valentina Lara Erazo, et al.
The Lancet. Diabetes & Endocrinology|December 7, 2023
Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trialKausik K Ray, Stephen J Nicholls, Na Li, et al.
American Heart Journal|June 1, 2002
Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET)A Michael Lincoff, Neal S Kleiman, Kandace Kottke-Marchant, et al.
The American Journal of Cardiology|March 23, 2021
Prediabetic Patient Outcomes 8 to 15 Years After Drug-Eluting Coronary StentingStephen G Ellis, Leslie Cho, Russell Raymond, et al.
JAMA|October 23, 2003
Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classificationUmesh N Khot, Gang Jia, David J Moliterno, et al.
Pageof 54